A study on application of impregnated synthetic peptide TLC stationary phases for the screening of 5-HT1A ligands. Part 2

Biomedical Chromatography

Volumn 18, Issue 8, 2004, Pages 542-549

  Zajdel, Paweł ^a   Bojarski, Andrzej J ^b   Bugno, Ryszard ^b   Jurczyk, Sławomir ^a   Kołaczkowski, Marcin ^a   Nowak, Mateusz ^b   Subra, Gilles ^c   Martinez, Jean ^c   Pawłowski, Maciej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c UNIV MONTPELLIER   (France)

Author keywords

5 HT1A receptor affinity; Arylpiperazine derivatives; Molecular dynamics analysis; Peptide impregnated TLC phases; Protein based affinity chromatography

Indexed keywords

AFFINITY CHROMATOGRAPHY; LIGANDS; MOLECULAR DYNAMICS;

5-HT1A RECEPTOR AFFINITY; ARYLPIPERAZINE DERIVATIVE; ARYLPIPERAZINES; MOLECULAR DYNAMIC ANALYSIS; PEPTIDE-IMPREGNATED TLC PHASE; PROTEIN-BASED AFFINITY CHROMATOGRAPHY; RECEPTOR LIGANDS; STATIONARY PHASE; SYNTHESISED; SYNTHETIC PEPTIDE;

PEPTIDES;

2 METHOXYPHENYLPIPERAZINE DERIVATIVE; ARYLPIPERAZINE DERIVATIVE; PIPERAZINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SYNTHETIC PEPTIDE; TETRAPEPTIDE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; PREDICTION; PROTEIN MODIFICATION; THIN LAYER CHROMATOGRAPHY; VALIDATION PROCESS;

EID: 5044238642     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.354     Document Type: Article

References (29)

1. Andrews P, Kitchen BJ and Winzor DJ. Use of affinity chromatography for the quantitative study of acceptor-ligand interactions: the lactose synthetase system. Biochemical Journal 1973; 135: 897.
2. Berendsen HJC, Postma JPM, van Gunsteren WF and Hermans J. Intermolecular Forces. Reidel: Dordrecht, 1981; 331.
3. Berendsen HJC, Postma JPM, DiNola A and Haak JR. Molecular dynamics with coupling to an external bath. Journal of Chemical Physics 1984; 81: 3684.
4. Berendsen HJC, van der Spoel D and van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Computer Physics Communications 1995; 91: 43.
5. Brekkan E, Lundqvist A and Lundahl P. Immobilized membrane vesicle or proteoliposome affinity chromatography. Frontal analysis of interactions of cytochalasin B and D-glucose with the human red cell glucose transporter. Biochemistry 1996; 35: 12141.
6. 2A receptor ligands. Archiv der Pharmazie Pharmaceutical and Medicinal Chemistry 1996; 329: 283.
7. 2A receptor ligands. Polish Journal of Pharmacology 2001; 53: 395.
8. 2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2.6-dione. Polish Journal of Pharmacology 2001; 53: 359.
9. Feng W, Graumann K, Hahn R and Jungbauer A. Affinity chromatography of human estrogen receptor-a expressed in Saccharomyces cerevisiae Combination of heparin- and 17β-estradiol-affinity chromatography. Journal of Chromatography A 1999; 852: 161.
10. van Gunsteren WF, Billeter SR, Eising AA, Huenenberger PH, Krueger P, Mark AE, Scott WRP and Tironi IG. Biomolecular Simulation: the GROMOS96 Manual and User guide. Hochschulverlag AG an der ETH: Zurich, 1996.
11. Hermkens PHH, Ottenheijm HCJ and Rees D. Solid phase organic reactions: a review of the recent literature. Tetrahedron 1996; 52: 4527.
12. Hess B, Bekker H, Berendsen HJC and Fraaije JGEM. A linear constraint solver for molecular simulations. Journal of Computational Chemistry 1997; 18: 1463.
13. 1A receptor agonist and definition of a steric model of this site. European Journal of Medicinal Chemistry 1989; 24: 31.
14. Jones BJ and Blackburn TP. The medical benefit of 5-HT research. Pharmacology, Biochemistry and Behavior 2002, 71: 555.
15. Lundqvist A and Lundahl P. Advantages of quantitative affinity chromatography for the analysis of solute interaction with membrane proteins. Journal of Biochemical and Biophysics Methods 2001; 49: 507.
16. Markoglou N and Wainer IW. On-line synthesis utilizing immobilized enzyme reactors based upon immobilized dopamine beta-hydroxylase. Journal of Chromatography B 2001; 766: 145.
17. 1A-receptor agonist based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin. Journal of Medicinal Chemistry 1991; 34: 497.
18. Moaddel R, Cloix JF, Ertem G and Wainer IW. Multiple receptor liquid chromatographic stationary phases: the co-immobilization of nicotinic receptors, γ-amino-butyric acid receptors, and N-methyl D-aspartate receptors. Pharmaceutical Research 2002; 19: 104.
19. Moaddel R and Wainer IW. Immobilized nicotinic receptor stationary phases: going with the flow in high-throughput screening and pharmacological studies. Journal of Pharmaceutical and Biomedical Analysis 2003; 30: 1715.
20. 2 ligands with a potential antipsychotic activity. Drug Desing and Discovery 1994a; 11: 197.
21. 1A receptors. Medicinal Chemistry Research 1994b; 4: 161.
22. 1A receptor antagonist, and its analogs. Journal of Medicinal Chemistry 1994c; 37: 2754.
23. 1A receptor activity of some analogs of MP 3022. Polish Journal of Pharmacology 1999; 51: 415.
24. 2A activity. Polish Journal of Pharmacology 2001; 53: 369.
25. 2A receptor activity. Archiv der Pharmazie (Weinheim) 2003a; 336: 104.
26. 2 receptor activity. Polish Journal of Pharmacology 2003b; 55 (in press).
27. 2A receptor affinity of new 1-phenylpiperazinylpropyl derivatives of purine-2,6- and pyrrolidine-2,5-diones. Il Farmaco 2000; 55: 461.
28. Woodbury ChP and Venton DL. Methods of screening combinatorial libraries using immobilized or restrained receptors. Journal of Chromatography B 1999; 725: 113.
29. 1A ligands. Biomedical Chromatography 2003; 17: 312.